Search…

Lates News

05/05/2026

Rheinmetall reaffirms its 2026 fiscal year performance guidance: revenue growth of 40%-45%, operating profit margin of approximately 19%, and cash conversion rate exceeding 40%. Revenue in the first quarter of 2026 was 1.938 billion euros, a year-on-year increase of 7.7%, lower than market expectations.

Latest

5 m ago

Coherus Oncology will release its financial performance for the first quarter of 2026 after the closing of the US stock market on May 11, 2026. The company's management team will hold a conference call and webcast at 5:00 pm Eastern Time on the same day to discuss the financial report and provide updates on the latest business developments.

7 m ago

Miami Herald reporter Julie K. Brown was awarded a special commendation for her coverage of the Jeffrey Epstein case.

7 m ago

According to the latest data, as of early May, the stocks with the highest short positions in the US healthcare sector include Sensei Biotherapeutics, KalVista Pharmaceuticals, and GlucoTrack. These companies are generally facing uncertainties in clinical results and questions about the strength of their balance sheets, making them prime targets for short selling.

8 m ago

The Washington Post wins the Pulitzer Prize for Public Service.

10 m ago

Canadian gold producer Agnico Eagle Mines announced on Monday that it has received approval from the Toronto Stock Exchange to renew its normal course issuer bid for repurchasing common shares.

See all latest